MCTS1_HUMAN - dbPTM
MCTS1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MCTS1_HUMAN
UniProt AC Q9ULC4
Protein Name Malignant T-cell-amplified sequence 1
Gene Name MCTS1
Organism Homo sapiens (Human).
Sequence Length 181
Subcellular Localization Cytoplasm . Nuclear relocalization after DNA damage.
Protein Description Anti-oncogene that plays a role in cell cycle regulation; decreases cell doubling time and anchorage-dependent growth; shortens the duration of G1 transit time and G1/S transition. When constitutively expressed, increases CDK4 and CDK6 kinases activity and CCND1/cyclin D1 protein level, as well as G1 cyclin/CDK complex formation. Involved in translation initiation; promotes recruitment of aminoacetyled initiator tRNA to P site of 40S ribosomes. Can promote release of deacylated tRNA and mRNA from recycled 40S subunits following ABCE1-mediated dissociation of post-termination ribosomal complexes into subunits. Plays a role as translation enhancer; recruits the density-regulated protein/DENR and binds to the cap complex of the 5'-terminus of mRNAs, subsequently altering the mRNA translation profile; up-regulates protein levels of BCL2L2, TFDP1, MRE11, CCND1 and E2F1, while mRNA levels remains constant. Hyperactivates DNA damage signaling pathway; increased gamma-irradiation-induced phosphorylation of histone H2AX, and induces damage foci formation. Increases the overall number of chromosomal abnormalities such as larger chromosomes formation and multiples chromosomal fusions when overexpressed in gamma-irradiated cells. May play a role in promoting lymphoid tumor development: lymphoid cell lines overexpressing MCTS1 exhibit increased growth rates and display increased protection against apoptosis. May contribute to the pathogenesis and progression of breast cancer via promotion of angiogenesis through the decline of inhibitory THBS1/thrombospondin-1, and inhibition of apoptosis. Involved in the process of proteasome degradation to down-regulate Tumor suppressor p53/TP53 in breast cancer cell; Positively regulates phosphorylation of MAPK1 and MAPK3. Involved in translation initiation; promotes aminoacetyled initiator tRNA to P site of 40S ribosomes. Can promote release of deacylated tRNA and mRNA from recycled 40S subunits following ABCE1-mediated dissociation of post-termination ribosomal complexes into subunits..
Protein Sequence MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAEGKQHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Acetylation----MFKKFDEKENV
----CCCCCCCCCCH
46.9425953088
8UbiquitinationMFKKFDEKENVSNCI
CCCCCCCCCCHHHHH
57.3329967540
14S-nitrosylationEKENVSNCIQLKTSV
CCCCHHHHHHHHHHH
1.3122178444
18MalonylationVSNCIQLKTSVIKGI
HHHHHHHHHHHHHHH
23.5226320211
18AcetylationVSNCIQLKTSVIKGI
HHHHHHHHHHHHHHH
23.5225953088
18UbiquitinationVSNCIQLKTSVIKGI
HHHHHHHHHHHHHHH
23.5233845483
19 (in isoform 3)Malonylation-36.5026320211
23AcetylationQLKTSVIKGIKNQLI
HHHHHHHHHHHHHHH
53.0526051181
23UbiquitinationQLKTSVIKGIKNQLI
HHHHHHHHHHHHHHH
53.0533845483
24 (in isoform 3)Ubiquitination-25.61-
24UbiquitinationLKTSVIKGIKNQLIE
HHHHHHHHHHHHHHH
25.6133845483
44SulfoxidationEPWLNQIMPKKDPVK
HHHHHHHCCCCCCCE
2.6128183972
51AcetylationMPKKDPVKIVRCHEH
CCCCCCCEEEECCCC
40.6523749302
52AcetylationPKKDPVKIVRCHEHI
CCCCCCEEEECCCCE
2.1119608861
75 (in isoform 2)Ubiquitination-63.9821890473
79PhosphorylationRQREGPFYPTLRLLH
ECCCCCCHHHHHHHH
9.8420068231
81PhosphorylationREGPFYPTLRLLHKY
CCCCCHHHHHHHHCC
17.0920068231
87 (in isoform 1)Ubiquitination-55.3721890473
87UbiquitinationPTLRLLHKYPFILPH
HHHHHHHCCCCCCCC
55.3723000965
87AcetylationPTLRLLHKYPFILPH
HHHHHHHCCCCCCCC
55.3723236377
88UbiquitinationTLRLLHKYPFILPHQ
HHHHHHCCCCCCCCC
7.8221890473
88UbiquitinationTLRLLHKYPFILPHQ
HHHHHHCCCCCCCCC
7.8221890473
88 (in isoform 3)Ubiquitination-7.82-
99UbiquitinationLPHQQVDKGAIKFVL
CCCCCCCCCHHHHHH
51.9229967540
992-HydroxyisobutyrylationLPHQQVDKGAIKFVL
CCCCCCCCCHHHHHH
51.92-
99AcetylationLPHQQVDKGAIKFVL
CCCCCCCCCHHHHHH
51.9219608861
100AcetylationPHQQVDKGAIKFVLS
CCCCCCCCHHHHHHC
28.2419608861
100UbiquitinationPHQQVDKGAIKFVLS
CCCCCCCCHHHHHHC
28.2429967540
103AcetylationQVDKGAIKFVLSGAN
CCCCCHHHHHHCCCC
28.9625953088
103UbiquitinationQVDKGAIKFVLSGAN
CCCCCHHHHHHCCCC
28.96-
107PhosphorylationGAIKFVLSGANIMCP
CHHHHHHCCCCEECC
30.4730622161
112SulfoxidationVLSGANIMCPGLTSP
HHCCCCEECCCCCCC
1.9521406390
117PhosphorylationNIMCPGLTSPGAKLY
CEECCCCCCCCCCCC
38.5025159151
118PhosphorylationIMCPGLTSPGAKLYP
EECCCCCCCCCCCCH
26.7825159151
124PhosphorylationTSPGAKLYPAAVDTI
CCCCCCCCHHHHHHH
7.0728348404
157AcetylationMSAEDIEKVNKGIGI
CCHHHHHHHHCCCCC
51.9823236377
157UbiquitinationMSAEDIEKVNKGIGI
CCHHHHHHHHCCCCC
51.9829967540
158UbiquitinationSAEDIEKVNKGIGIE
CHHHHHHHHCCCCCE
6.0829967540
160UbiquitinationEDIEKVNKGIGIENI
HHHHHHHCCCCCEEE
55.6921963094
161 (in isoform 3)Ubiquitination-20.39-
161UbiquitinationDIEKVNKGIGIENIH
HHHHHHCCCCCEEEE
20.3921963094
177SulfoxidationLNDGLWHMKTYK---
ECCCEECEEECC---
2.0430846556
178AcetylationNDGLWHMKTYK----
CCCEECEEECC----
35.5025953088
178UbiquitinationNDGLWHMKTYK----
CCCEECEEECC----
35.50-
179 (in isoform 3)Ubiquitination-29.03-
181UbiquitinationLWHMKTYK-------
EECEEECC-------
60.12-
182 (in isoform 3)Ubiquitination--

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
81TPhosphorylationKinaseERK2P28482
PSP
81TPhosphorylationKinaseERK1P27361
PSP
118SPhosphorylationKinaseCDK1P06493
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MCTS1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MCTS1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
DENR_HUMANDENRphysical
16169070
ASB6_HUMANASB6physical
22863883
PUR9_HUMANATICphysical
22863883
HDGF_HUMANHDGFphysical
22863883
HMGB3_HUMANHMGB3physical
22863883
IPO5_HUMANIPO5physical
22863883
IPO9_HUMANIPO9physical
22863883
ISOC1_HUMANISOC1physical
22863883
PLPHP_HUMANPROSCphysical
22863883
UBA1_HUMANUBA1physical
22863883
UBP5_HUMANUSP5physical
22863883
1433E_HUMANYWHAEphysical
22863883
COR1C_HUMANCORO1Cphysical
26344197
DENR_HUMANDENRphysical
26344197
DENR_HUMANDENRphysical
21516116

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MCTS1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-51, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Phosphorylation of MCT-1 by p44/42 MAPK is required for itsstabilization in response to DNA damage.";
Nandi S., Reinert L.S., Hachem A., Mazan-Mamczarz K., Hagner P.,He H., Gartenhaus R.B.;
Oncogene 26:2283-2289(2007).
Cited for: FUNCTION, PHOSPHORYLATION AT THR-81 AND SER-118, AND MUTAGENESIS OFTHR-81 AND SER-118.

TOP